A digital twin fed with data from non-invasive sensor systems attached to the skin, by contrast, enables the precise and personalized dosage of the active agents. The computer modelling of the digital doppelganger also factors in the patient’s skin characteristics. After all, the active agent will be absorbed differently depending on where the plaster is attached to the body or whether the drug is administered to a sun-tanned athlete, an elderly lady with pale, papery skin or a soft-skinned newborn. Thus the drug dosage can be controlled precisely thanks to a tailored, time-dependent rate of expulsion from the bandage because the system looks into the future, not back. “As an extra benefit, we expect to be able to reduce the dosage – of painkillers, for instance – to such an extent that the patient is supplied with just the right amount,” says Defraeye.
In other research fields, virtual representatives have been a hot topic ever since NASA’s Apollo 13 mission. Doppelgangers were used in simulations to bring the crew of the stricken spaceship safely back to Earth. Today, digital twins exist in aircraft design, vehicle manufacturing and building maintenance, for example. “In medicine, people dream of complete in silico doppelgangers, which predict how a person will age or how an artificial joint will wear in the body,” says Defraeye. However, we are still a long way from this becoming a reality. The novel system consisting of intelligent plasters and real-time simulations is, therefore, a crucial step into an as yet little researched area with enormous potential, the Empa researcher explains. At the same time, the personalized digital twin for the transdermal administration of drugs takes us a step closer towards human avatars.
For the development of the digital twin in the healthcare sector, Defraeye has successful research results to build upon: In the food technology sector, he has already developed digital twins of different fruits as part of an ongoing project funded by the Swiss National Science Foundation (SNSF). In order to monitor the cooling chain from the producer to the retailer in real-time and be able to control it in future, the researcher made biophysical twins of apples, mangos and other fruits that behave in exactly the same way as their natural counterparts in terms of their thermal properties and that act as sensors. The corresponding “fruit spy” accompanies the real fruit on its journey to the supermarket and transmits data to the digital twin, which adjusts the cooling in the truck, for instance. In this case, the virtual fruit is based on a three-dimensional CAD model of an apple or a mango combined with corresponding multiphysical simulations.
For the transdermal treatment avatar, the Empa researchers will program a complex multiphysical skin model, which is fed with data from sensors on the skin. Biophysical twins of the person, dubbed manikins, are used as helpers for the development of the sensors. Based on the information from the sensor-covered mannequins, physiological values and reactions of a real patients can be estimated, such as changes in skin temperature or perspiration rate. The manikins and a linked-up computer model are already an established system at Empa for simulating human physiological responses. The system will now be used to set up the considerably more complex digital human doppelgangers, which are governed by a vast number of variables. “After all, not only does the virtual twin have to respond to changes; it also needs to predict drug dosage safely and individually,” says Defraeye.